3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Gemcitabine
2
Aminolevulinic Acid
2
toripalimab
1
tirbanibulin
1
ruxolitinib
1
potassium oxonate
1
penpulimab
1
human papillomavirus vaccine, L1 type 16, 18
1
gimeracil
1
apatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Toremifene
1
Tegafur
1
Robotic Surgical Procedures
1
Rifampin
1
RAD140
1
Pregnancy Tests
1
Pemetrexed
1
ON 01910
1
Nivolumab
1
Itraconazole
1
Irinotecan
1
Injections
1
Infusions, Intravenous
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
High-Intensity Focused Ultrasound Ablation
1
Excipients
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Transurethral Resection of Prostate
×
Other neoplasm
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled